Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
10/2009
10/22/2009WO2009077956A3 HETEROCYCLIC INHIBITORS OF AN Hh-SIGNAL CASCADE, MEDICINAL COMPOSITIONS BASED THEREON AND METHODS FOR TREATING DISEASES CAUSED BY THE ABERRANT ACTIVITY OF AN Hh-SIGNAL SYSTEM
10/22/2009WO2008110355A8 Quinoline derivatives as fungicides
10/22/2009US20090264653 Useful indole compounds
10/22/2009US20090264464 Antitumor agent for undifferentiated gastric cancer
10/22/2009US20090264435 Novel Aryl- and Heteroarylpiperazines
10/22/2009US20090264424 Vanilloid receptor ligands and their use in treatments
10/22/2009US20090263488 Pressurised metered dose inhalers containing solutions of beta-2 agonists
10/22/2009CA2721785A1 New arylsulphonylglycine derivatives, the preparation thereof and their use as medicaments
10/22/2009CA2718538A1 Quinoline derivatives as axl kinase inhibitors
10/21/2009EP2109603A1 Process for the preparation of 8-hydroxy-5-[(1r)-1-hydroxy-2[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]-ethyl]-2(1h)-quinolinone monohydrochloride
10/21/2009EP1513531B1 Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom
10/21/2009EP1363980B1 Luminescent polymers
10/21/2009EP1280776B1 Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis
10/21/2009CN101563347A Vasopressin V1a antagonists
10/21/2009CN101563318A N- (5, 6, 7, 8-tetrahydronaphthalen-1-yl) urea derivatives and related compounds as trpv1 vanilloid receptor antagonists for the treatment of pain
10/21/2009CN101562234A Organic electroluminescent display element
10/21/2009CN101562232A Color-adjustable organic electroluminescent device and preparation method thereof
10/21/2009CN101560184A N-chiral quaternary ammonium salt derived from amino acid and preparation method thereof
10/21/2009CN101560158A Novel organic electroluminescent compounds and organic electroluminescent device using the same
10/20/2009US7605267 Process for the preparation of 5-(halocetyl)-8-(substituted oxy)-(1h)-quinolin-2-ones
10/15/2009WO2009125597A1 Acylthiourea compound or salt thereof, and use of the compound or the salt
10/15/2009US20090259044 Compositions and methods for modulating sirtuin activity
10/15/2009US20090258884 Substituted amides
10/15/2009CA2720552A1 Acylthiourea compound or salt thereof, and use thereof
10/14/2009EP1720829B1 Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors
10/14/2009EP1687276B1 Novel method of preparing 3-fluorinated quinolines
10/14/2009CN101558042A Method of preparing montelukast and intermediates used therein
10/14/2009CN101555225A Method for preparing poly-substituted quinoline compound
10/13/2009US7601842 Asymmetric hydrogenation of enaminoesters without protecting the secondary amino group with a protective group; good asymmetric, chemical yields and workability; methyl (2R,4S)-(2-ethyl-6-trifluoromethyl-1,2,3,4-tetrahydroquinolin-4-yl)carbamate
10/13/2009US7601841 Quinolinyl and benzothiazolyl modulators
10/13/2009US7601837 Quinoline derivatives and their use as 5-HT6 ligands
10/13/2009US7601741 decyclization of {3-[(E)-2(7-chloro-2-quinolinyl)vinyl]phenyl}-4,5-dihydro-3H-benzo[c]thiepin-1-one by methylmagnesium halide with following conversion to montelukast
10/13/2009US7601674 α-oxygenated or α-thiolated carboxylic acid phenethylamide derivatives
10/13/2009CA2341678C Potassium channel inhibitors and method
10/08/2009WO2009123241A1 Inhibitor of plasminogen activator inhibitor-1
10/08/2009WO2009123194A1 Heterocyclic compound
10/08/2009WO2009122034A2 Novel hsp90 inhibitory carbazole derivatives, compositions containing same, and use thereof
10/08/2009US20090253908 Novel m3 muscarinic acetylchoine receptor antagonists
10/08/2009US20090253740 Substituted n-bicyclicalkyl bicycliccarboxyamide compounds
10/08/2009US20090253739 Amine Derivatives
10/08/2009US20090253726 Tri-, tetra-substituted-3-aminopyrrolidine derivative
10/08/2009US20090253656 Bcrp/abcg2 inhibitor
10/08/2009US20090253655 Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indications
10/08/2009CA2718488A1 Novel dhsp90 inhibitory carbazole derivatives, compositions containing same, and use thereof
10/07/2009EP2107052A1 Novel n-(2-aminophenyl)benzamide derivative having an urea structure
10/07/2009EP1709027B1 Hydrazide type compounds and the use thereof in pharmaceutical compositions for the treatment of cardiovascular diseases
10/07/2009CN101553472A Tetrahydronaphthaline derivatives, methods for the production and use thereof as anti-inflammatory agents
10/07/2009CN101553471A 抗菌喹啉衍生物 Antibacterial quinoline derivatives
10/07/2009CN101553470A Antibacterial quinoline derivatives
10/07/2009CN101553469A Carboxylic acid derivative
10/07/2009CN100546977C New compounds for the inhibition of rotamases and use thereof
10/06/2009US7598412 Cystic fibrosis transmembrane conductance regulator; ABC transporter mediated diseases like cystic fibrosis; 5-methoxy-N-((1-(3,4-dimethoxyphenyl)-cyclohexyl)methyl)benzofuran-2-carboxamide; or sulfonamide analogs; chloride or bicarbonate channel modulators
10/06/2009US7598390 1-Benzyl-4-methyl-2-(1-methylimidazoyl)-quinolinium acetate, for example; compounds are stains that become fluorescent upon illumination and interaction with double stranded DNA, but exhibit reduced or no fluorescence in the absence of double stranded DNA
10/06/2009US7598385 Reacting unsubstituted or substituted 2-methylbenzothiazole, 2-methylbenzooxazole or 2,3,3-trimethyl-3H-indoline with substituted or unsubstituted benzylhalide, forming 4-methylquinoline quaternary ammonium salt intermediates, condensing with N,N'-diphenylformamidine; for staining nucleic acids
10/06/2009US7598384 Specific binding is extremely high; low toxicity; high degree of activity; 2-(5-m-Tolyl-thiazol-2-yl )-7,8-dihydro-6H-quinolin-5-one, acute and/or chronic neurological disorders
10/06/2009US7598383 mitogen activated protein kinase inhibitors; 4-(2-fluoro-4-methylphenylamino)-1,3-dimethyl-6,7-dihydro-1H-pyrrolo[3,4-b]pyridine-2,5-dione; used in the treatment of hyperproliferative diseases, such as cancer and inflammation in mammals
10/06/2009US7598263 9-[(3-hydroxy-5-methoxyphenyl)amino]-1,2-dihydrothieno[3,2-f]quinoline-8-carbonitrile 3,3-dioxide; protein tyrosine kinases inhibitor, especially erythropoetin-producing hepatoma amplified sequence (Eph) receptors antagonist; antitumor, angiogenesis inhibitor, neurodegenerative diseases
10/06/2009US7598258 Quinoline derivatives and quinazoline derivatives inhibiting autophosphorylation of macrophage colony stimulating factor receptor
10/06/2009US7598242 Compounds for the treatment of inflammatory disorders
10/06/2009US7598236 Diazabicyclic central nervous system active agents
10/06/2009US7597926 Electroluminescent quinolates
10/06/2009CA2301377C N-aroylphenylalanine derivatives
10/06/2009CA2291048C Dehydration plant
10/06/2009CA2258924C Cftr channel activator compounds and pharmaceutical compositions containing same
10/01/2009WO2009120774A2 Method of preparing huperzine a and derivatives thereof
10/01/2009WO2009119817A1 Stable vinamidinium salt and nitrogen-containing heterocyclic ring synthesis using the same
10/01/2009WO2009117484A2 Small molecule e2f inhibitor
10/01/2009WO2009087098A3 Quinoline derivatives and their use as fungicides
10/01/2009WO2009060835A8 Novel ubiquilin-binding small molecule
10/01/2009WO2009049716A3 Novel fungicides
10/01/2009US20090247761 Preparation of 3,4-Dihydroisoquinolines in the Synthesis of Morphinans
10/01/2009US20090247760 Preparation of Amides from an Acid and Amine for Intermediates in the Synthesis of Morphinans
10/01/2009US20090247759 Purification process of Montelukast and its Amine Salts
10/01/2009US20090247758 Novel Quinoline Compound, and Composition Containing Centipede Extract or Compounds Isolated Therefrom for Prevention and Treatment of Cardiovascular Disease
10/01/2009US20090247754 Method of preparing huperzine a and derivatives thereof
10/01/2009US20090247745 adenosine A3 receptor antagonists; improved bioavailability; treatment of diseases such as asthma, COPD and ARDS, glaucoma, tumor, allergic and inflammatory diseases, ischemia, hypoxia, arrythmia and renal diseases; e.g. 4-Methoxy-N-[6-(morpholin-4-yl)-4-benzylamino-3-cyanoquinolin-2-yl]-benzamide
10/01/2009US20090247731 Boronic ester and acid compounds, synthesis and uses
10/01/2009US20090247578 5-hydroxymethyl-oxazolidin-2-one-derivatives and their uses as antibacterials
10/01/2009US20090247576 Anti-tumor agent for multiple myeloma
10/01/2009US20090247509 for treating central nervous system disorders such as psychological disorders, drug dependence and abuse, dyskinesia, dementia, anxiety disorders, sleep disorders and mood disorders
10/01/2009US20090247506 Antibacterial agents
09/2009
09/30/2009EP2105443A1 Oxime derivatives and their use in photopolymerizable compositions for colour filters
09/30/2009EP1962849B1 Quinoline derivatives useful in the treatment of mglur5 receptor-mediated disorders
09/30/2009EP1711181B1 Quinoline derivatives and use thereof as mycobacterial inhibitors
09/30/2009CN101547907A 抗菌的喹啉衍生物 Antibacterial quinoline derivatives
09/30/2009CN101547906A Antibacterial quinoline derivatives
09/30/2009CN101547905A Antibacterial quinoline derivatives
09/30/2009CN101547904A Fumarate salt of (alpha S, beta R)-6-bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol
09/30/2009CN101544602A Fleroxacin lactate and preparation method thereof
09/30/2009CN101544601A Method for synthesizing 5,6,7,8-tetrahydroquinoline
09/29/2009US7595501 Electroluminescent iridium compounds with fluorinated phenylpryidines, phenylpyrimidines, and phenylquinolines and devices made with such compounds
09/29/2009US7595402 Treating dry eye, use as male contraceptive, or against prostate cancer; ester, carbonate, glycoside prodrugs of SARMS such as N-(4-Cyano-3-trifluoromethylphenyl)-3-(p-fluorophenoxy)-2-hydroxy-2-methyl-propionamide; bioavailability
09/29/2009US7595399 Tyrosine derivatives
09/29/2009US7595343 Inhibitors of histone deacetylase
09/29/2009CA2176796C Substituted benzyloxycarbonylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
09/24/2009WO2009117381A2 Preparation of montelukast and its salts
09/24/2009WO2009115257A1 Substituted sulfonamide derivatives
09/24/2009WO2009024611A3 4-benzylaminoquinolines, pharmaceutical compositions containing them and their use
09/24/2009US20090240053 2-(4-(1-methyl-4-piperidinoxy)benzylamino)-2-methyl-propanamide; nervous system disorders; analgesics; anticonvulsants; sodium channel moderators; antidepressants, antiarrhythmics and for the treatment or prevention of diabetic neuropathy
09/24/2009US20090239906 Alkoxyalkyl-substituted cyclic ketoenols
1 ... 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 ... 277